Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis

Molecular Biology Reports

Volumn 39, Issue 12, 2012, Pages 10063-10075

  Li, Xiaobo ^a,b   Li, Yuqiong ^a,b   Jia, Nan ^a,b   Guo, Shujie ^a,b   Chu, Shaoli ^a,b   Niu, Wenquan ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Hypertension   (China)

Author keywords

Angiotensin converting enzyme; Association study; Left ventricular hypertrophy; Meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; CASE CONTROL STUDY; ENZYMOLOGY; GENE DELETION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INDEL MUTATION; META ANALYSIS; RISK;

ALLELES; CASE-CONTROL STUDIES; GENE DELETION; GENETIC ASSOCIATION STUDIES; GENETIC HETEROGENEITY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INDEL MUTATION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK;

EID: 85027955517     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1875-6     Document Type: Article

References (63)

1. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S et al (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634–1638
2. Nogueira JB (2005) Genetics of left ventricular hypertrophy and its regression. Rev Port Cardiol 24:105–117
3. Arnett DK, de las Fuentes L, Broeckel U (2004) Genes for left ventricular hypertrophy. Curr Hypertens Rep 6:36–41
4. Sasaki M, Oki T, Iuchi A, Tabata T, Yamada H et al (1996) Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 14:1403–1408
5. Xiao HD, Fuchs S, Campbell DJ, Lewis W, Dudley SC Jr et al (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165:1019–1032
6. Rigat B, Hubert C, Corvol P, Soubrier F (1992) PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P et al (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Investig 86:1343–1346
8. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR et al (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387–1388
9. Niu W, Qi Y (2011) Association of alpha-adducin and G-protein beta3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS ONE 6:e17052
10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
11. Bowden J, Tierney JF, Copas AJ, Burdett S (2011) Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 11:41
12. Celentano A, Mancini FP, Crivaro M, Palmieri V, Ferrara LA et al (1999) Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol 83:1196–1200
13. Clarkson PB, Prasad N, MacLeod C, Burchell B, MacDonald TM (1997) Influence of the angiotensin converting enzyme I/D gene polymorphisms on left ventricular diastolic filling in patients with essential hypertension. J Hypertens 15:995–1000
14. Coto E, Palacin M, Martin M, Castro MG, Reguero JR et al (2010) Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier. J Transl Med 8:64
15. Di Mauro M, Izzicupo P, Santarelli F, Falone S, Pennelli A et al (2010) ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes. Med Sci Sports Exerc 42: 915–921
16. Fernandez-Llama P, Poch E, Oriola J, Botey A, Rivera F et al (1998) Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: relation with target organ damage. Am J Hypertens 11:439–444
17. Frossard PM, Hill SH, Elshahat YI, Obineche EN, Bokhari AM et al (1998) Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a Gulf population. Clin Genet 54:285–293
18. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA (1996) Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 77:1315–1319
19. Gomez-Angelats E, de la Sierra A, Enjuto M, Sierra C, Oriola J et al (2000) Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension. J Hum Hypertens 14:47–49
20. Hernandez D, de la Rosa A, Barragan A, Barrios Y, Salido E et al (2003) The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes. J Am Coll Cardiol 42:527–532
21. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M (1994) DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622–2628
22. Jeng JR (2000) Carotid thickening, cardiac hypertrophy, and angiotensin converting enzyme gene polymorphism in patients with hypertension. Am J Hypertens 13:111–119
23. Kasikcioglu E, Kayserilioglu A, Ciloglu F, Akhan H, Oflaz H et al (2004) Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes. Heart Vessels 19:287–293
24. Kato N, Tatara Y, Ohishi M, Takeya Y, Onishi M et al (2011) Angiotensin-converting enzyme single nucleotide polymorphism is a genetic risk factor for cardiovascular disease: a cohort study of hypertensive patients. Hypertens Res 34:728–734
25. Kauma H, Ikaheimo M, Savolainen MJ, Kiema TR, Rantala AO et al (1998) Variants of renin-angiotensin system genes and echocardiographic left ventricular mass. Eur Heart J 19:1109– 1117
26. Kim HS, Lee MM, Oh BH, Kim KI, Han KH et al (2000) Synergistic effect of angiotensin-converting enzyme and angiotensinogen gene on cardiac hypertrophy. Int J Cardiol 72:151–161
27. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ (1994) Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 267:H1107–H1111
28. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA et al (1996) Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 334:1023–1028
29. Makeeva OA, Puzyrev KV, Pavliukova EN, Koshel’skaia OA, Golubenko MV et al (2004) ACE and AGTR1 genes polymorphisms in left ventricular hypertrophy pathogenesis in humans. Mol Biol (Mosk) 38:990–996
30. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA et al (1997) Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741–747
31. Obineche EN, Frossard PM, Bokhari AM (2001) An association study of five genetic loci and left ventricular hypertrophy amongst Gulf Arabs. Hypertens Res 24:635–639
32. Obineche EN, Frossard PM, Bokhari AM (2002) Association between an ANF Gene I/D dimorphism and left ventricular hypertrophy in a Gulf Arab population. Ann Saudi Med 22:22–25
33. Olcay A, Nisanci Y, Ekmekci CG, Umman B, Bugra Z et al (2006) Aldosterone synthase-344C/T and angiotensin-converting enzyme I/D polymorphisms in Turkish hypertensive patients with normal coronary arteries. Acta Cardiol 61:29–34
34. Osono E, Kurihara S, Hayama N, Sakurai Y, Ohwada K et al (1998) Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease. Am J Kidney Dis 32:725–730
35. Pan M, Zhu JH, Liu ZH, Jiang WP, Cui ZC et al (2007) Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension. Hypertens Res 30:31–37
36. Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A et al (1997) Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol 29:365–369
37. Perticone F, Maio R, Cosco C, Ceravolo R, Iacopino S et al (1999) Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res 43:192–199
38. Rizzo M, Gensini F, Fatini C, Manetti P, Pucci N et al (2003) ACE I/D polymorphism and cardiac adaptations in adolescent athletes. Med Sci Sports Exerc 35:1986–1990
39. Saeed M, Saleheen D, Siddiqui S, Khan A, Butt ZA et al (2005) Association of angiotensin converting enzyme gene polymorphisms with left ventricular hypertrophy. Hypertens Res 28:345–349
40. Ueno H, Takata M, Yasumoto K, Tomita S, Inoue H (1999) Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy. Jpn Heart J 40:589–598
41. West MJ, Summers KM, Burstow DJ, Wong KK, Huggard PR (1994) Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy. Clin Exp Pharmacol Physiol 21:207–210
42. Wong KK, Summers KM, Burstow DJ, West MJ (1995) Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction. Clin Exp Pharmacol Physiol 22:438–440
43. Shen D, Ha D (1998) The relationship between angiotensin converting enzyme genotypes and hypertension complicated with left ventricular hypertrophy. Chin J Med Genet 15:364–366
44. Shen D, Ha D, Bai C (2001) Investigation of angiotensin converting enzyme genetic polymorphism and hypertension complicated with left ventricular hypertrophy in older subjects. Chin J Gerontol 21:186–188
45. Xiang G, Wang Y (2002) The relationship between angiotensin converting enzyme gene and hypertension complicated with left ventricular hypertrophy in patients with type 2 diabetes mellitus. Chin J Diabetes 10:180–181
46. Zhao D, Zhang R, Song W (2003) ACE gene polymorphism relating to essential hypertension and left ventricular hypertrophy. Mod Med Health 19:1526–1527
47. Wang J, Jiang M, Wang X, Wu X (2005) A study on the relationship between essential hypertension and the polymorphism of angiotensin-converting enzyme receptor gene. Acta Acad Med Xuzhou 25:520–522
48. Yu D, Qiao W, Xu Z, Zuo L, Ren X et al (2010) The relationship between angiotensin II type 1 receptor genetic polymorphism and left ventricular hypertrophy. Shandong Med J 50:55–56
49. Lin Y, Yin Y, Yang M, Tao J, Yin L et al (2003) Renin-angiotensin system gene polymorphisms and left ventricular hypertrophy in essential hypertension: an association study. Chin J Geriatr Cardiovasc Cerebrovasc Dis 5:86–89
50. Liao X, Zhang R, Hu Y, Wang S, Dong S (2005) A study on angiotensin converting enzyme gene polymorphisms in essential hypertension patients with left ventricular hypertrophy. J Chin Physician 7:462–464
51. Liang R (2008) The relationship between AGT, ACE and eNOS gene polymorphisms and hypertension and left ventricular hypertrophy. Dissertation for Master Degree, Guangdong Medical College
52. Li X, Gao C (1999) A study on angiotensin converting enzyme gene polymorphism and hypertension with left ventricular hypertrophy. Chin Hypertens J 7:311–313
53. Gao D, Gao L, Zhao S, Li C, Dai Y et al (2010) The association between hypertension with left ventricular hypertrophy and ACE/ ID polymorphisms. Mol Cardiol China 6:328–331
54. He H, Li L, Cao W, Sun N, Liu M et al (2004) Association between the I/D polymorphism of the ACE gene, A/B polymorphism of the chymase gene and left ventricular hypertrophy in essential hypertension. Chin J Hypertens 12:39–43
55. Deng Y, Huang D, Cheng Y (1999) A study on angiotensin converting enzyme gene polymorphism and left ventricular hypertrophy in essential hypertension. Chin J Cardiol 27:127–134
56. Kuznetsova T, Staessen JA, Wang JG, Gasowski J, Nikitin Y et al (2000) Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens 14:447–454
57. Yu J, Kuznetsova T, Thijs L, Richart T, Stolarz-Skrzypek K et al (2011) Association of echocardiographic left ventricular structure with the ACE D/I polymorphism: a meta-analysis. J Renin Angiotensin Aldosterone Syst 12:243–253
58. Hemminki K, Lorenzo Bermejo J, Forsti A (2006) The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 7:958–965
59. Yu K, Zhang J, Dou C, Gu S, Xie Y et al (2010) Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet 18:370–378
60. Baessler A, Kwitek AE, Fischer M, Koehler M, Reinhard W et al (2006) Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: results of the MONICA/KORA Augsburg Echocardiographic Substudy. Hypertension 47:920–927
61. Zhu H, Wang X, Dong Y, Treiber FA, Snieder H (2005) Influence of the eNOS gene on development of blood pressure and left ventricular mass: longitudinal findings in multiethnic youth. Pharmacogenet Genomics 15:669–675
62. Burrell LM, Burchill L, Dean RG, Griggs K, Patel SK, et al. (2011) Chronic kidney disease: cardiac and renal angiotensin converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Exp Physiol 97:477–485
63. Barton M, Meyer MR (2009) Postmenopausal hypertension: mechanisms and therapy. Hypertension 54:11–18